Commentary on 'Pamidronate: treatment for severe hypercalcemia in neonatal subcutaneous fat necrosis' by Alos N. et al., Hormone Research 2006;65:289-294.
Lombet
Jacques
J
D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D002118:Calcium / Q000378:metabolism; D004164:Diphosphonates / Q000008:administration & dosage / Q000627:therapeutic use*; D005218:Fat Necrosis / Q000150:complications* / Q000473:pathology; D005260:Female; D006801:Humans; D006934:Hypercalcemia / Q000188:drug therapy* / Q000209:etiology; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy*; D008297:Male; D000077268:Pamidronate; D012189:Retrospective Studies; D050151:Subcutaneous Fat / Q000473:pathology
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D000077268:Pamidronate; D002118:Calcium